Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (8,279,020) $ (6,462,677)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 67,091 54,661
Stock-based compensation expense 234,450 281,722
Change in fair value of derivative liability (3) (53,178)
Amortization of debt discount 0 314,925
Estimate for legal contingency 30,329 0
Loss from divestiture of asset 307,086 0
Debt conversion inducement expense 1,383,285 0
Accrued interest conversion expense (15,952) 0
Foreign currency remeasurement gain (45,350) 0
Changes in assets and liabilities:    
Prepaid expenses 714,152 (41,674)
Prepaid expenses - related party 0 13,432
Other current assets (432,975) (56,316)
Other current assets - related party 0 (12,655)
Accounts payable (118,487) (34,022)
Accounts payable - related parties (16,600) 105,107
Accrued interest - related party 0 86,736
Accrued payroll liabilities 256,198 5,798
Operating lease liability (45,794) (39,722)
Other current liabilities (28,995) (33,764)
Other current liabilities - related parties (94,078) 55,668
Net cash used in operating activities (6,052,759) (5,815,959)
Cash flows from investing activities:    
Proceeds from asset sale, net of legal expenses 5,532,266 0
Asset acquisition costs 0 (80,830)
Purchase of property and equipment (1,860) (5,212)
Net cash provided by (used in) investing activities 5,530,406 (86,042)
Cash flows from financing activities:    
Repayment of insurance premium loan payable (168,720) (153,076)
Net cash used in financing activities (168,720) (151,109)
Net increase (decrease) in cash and restricted cash (691,073) (6,053,110)
Cash, cash equivalents and restricted cash, beginning of period 1,249,107 8,987,578
Cash, cash equivalents and restricted cash, end of period 558,034 2,934,468
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 553,443 2,929,895
Restricted cash 4,591 4,573
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 558,034 2,934,468
Cash paid during the period for:    
Interest 8,533 2,669
Income taxes 8,741 5,141
Supplemental disclosures of non-cash financing activities:    
Common stock warrant exercises 282,905 0
Conversion of multi-draw credit agreement 1,565,470 0
Conversion of accrued interest due to related party 31,766 0
Purchases of property and equipment in other current liabilities 0 761,364
Financing of insurance premium 203,884 275,537
Release of share liability to additional paid-in-capital 0 13,000
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 241,134 0
Prefunded Warrants    
Cash flows from financing activities:    
Proceeds from pre-funded warrant exercises $ 0 $ 1,967